COCRYSTAL PHARMA, INC. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number
COCRYSTAL PHARMA, INC. (COCP) had Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number of 7.22 million shares as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber · last filed 2026-08-13
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 7.22M shares.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 7.22M shares.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 7.22M shares.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 5.74B shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number as first filed |
|---|---|---|
| 2026-06-30 | 7.22M shares 10-Q · filed 2026-08-13 | |
| 2026-03-31 | 7.22M shares 10-Q · filed 2026-05-15 | |
| 2025-12-31 | 7.22M shares 10-Q · filed 2026-05-15 | |
| 2025-09-30 | 5.74B shares 10-Q · filed 2025-11-14 | |
| 2021-03-31 | 2.26M shares 10-Q · filed 2021-05-17 | |
| 2020-12-31 | 2.26M shares 10-K · filed 2021-03-17 | |
| 2020-09-30 | 2.72M shares 10-Q · filed 2020-11-13 | |
| 2020-06-30 | 2.72M shares 10-Q · filed 2020-08-06 | |
| 2020-03-31 | 3.60M shares 10-Q · filed 2021-05-17 | |
| 2019-12-31 | 3.59M shares 10-K · filed 2021-03-17 | |
| 2019-09-30 | 3.59M shares 10-Q · filed 2019-11-12 | |
| 2019-06-30 | 3.59M shares 10-Q · filed 2020-11-13 | 3.53M shares 10-Q · filed 2019-08-09 |
| 2019-03-31 | 1.02M shares 10-Q · filed 2020-05-13 | |
| 2018-12-31 | 873.00K shares 10-K · filed 2020-03-27 | |
| 2018-09-30 | 1.81M shares 10-Q · filed 2019-11-12 | 888.00K shares 10-Q · filed 2018-11-09 |
| 2018-06-30 | 1.81M shares 10-Q · filed 2019-08-09 | |
| 2018-03-31 | 1.81M shares 10-Q · filed 2019-05-10 | |
| 2017-12-31 | 1.66M shares 10-K · filed 2019-04-01 | |
| 2017-09-30 | 49.67M shares 10-Q · filed 2017-11-08 | |
| 2017-06-30 | 49.67M shares 10-Q · filed 2017-08-08 | |
| 2017-03-31 | 49.34M shares 10-Q · filed 2017-05-10 | |
| 2016-12-31 | 1.61M shares 10-K · filed 2018-03-21 | 48.37M shares 10-K · filed 2017-03-31 |
| 2015-12-31 | 29.48M shares 10-K · filed 2017-03-31 | 29.48K shares 10-K · filed 2016-03-15 |
| 2014-12-31 | 32.82K shares 10-K · filed 2016-03-15 | 32.82M shares 10-K · filed 2015-03-31 |
| 2013-12-31 | 1.65K shares 10-K · filed 2016-03-15 | 1.65M shares 10-K · filed 2015-03-31 |
| 2012-12-31 | 1.77M shares 10-K · filed 2015-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |